aet reiter buy
share ytd sinc report earn august
compani reveal pbm retain rel benign portion
rebat collect behalf client also sinc earn
date report surfac aet transact near close
believ also contribut recent strong perform share
littl pro-forma detail exist point expect detail pro-
forma nancial outlook compani come shortli close
deal number catalyst horizon ie deal close guidanc
analyst day reiter view share
room run primarili driven multipl expans unlik broader
suppli chain share struggl year battl headlin relat
amazon intent pharmaci eventu pillpack acquisit potenti
drug price legisl weak long term care busi ad
confus believ consensu estim like vari treatment
aet deal relat nanc expens result wide adj ep rang
report publish rst attempt
integr pro-forma cvs-aet model revis estim
avail inform date see detail paragraph light latest
thought revis estim thought would help set stage
believ number could shake compar
gure compani across manag care space
price sep
revis estim reect close aet
expect signic amount guidanc post close deal
thought would help revis estim publish
model base inform point new pro-forma
model assum transact close divest
medicar pdp busi also satisfi potenti anti-trust concern
pleas see bodi note detail also increas capit
expenditur project particularli follow compani
preliminari free cash ow debt estim releas ling
revis estim pf model suggest conuenc
factor may caus consensu tick modestli lower
increas believ substanti cash gener abil pro-
forma entiti allow compani de-lev acceler pace move
gross debt ttm ebitda end end
distribut gmt
deutsch bank seek busi compani cover research report thu investor
awar rm may conict interest could aect object report investor consid
report singl factor make invest decis disclosur analyst certif
ev/ebitda basi estim share current trade
given pro-forma debt load price-to-earnings basi share continu screen
cheap trade basi cheapest
compani xlv index see bodi note detail
rais capital-expenditure assumpt assum signic invest close
ling juli releas certain prospect nancial inform
request connecticut insur depart prospect nancial
inform includ well estim free cash ow
well use avail cash dividend debt repay compani
free cash ow estim
estim gener ocf
similarli consensu estim aet suggest free cash ow
excess given delta estim free cash ow
year state pf free cash ow estim believ
compani may foreshadow signic invest infrastructur
retail pharmaci footprint rais capital-expenditure assumpt
reect interpret disclosur
pro-forma balanc sheet lever ebitda expect
stand-alon debt transact nanc
debt term loan similarli aetna gross debt
total pro-forma combin debt year end estim
paid littl princip remain balanc
current ebitda estim aet
respect combin pre-synergi pro-forma ebitda pro-
forma leverag note leverag slightli may
guidanc leverag gure call debt trail twelv month
ebitda suspect nancial detail compani follow close
transact includ detail earn guidanc greater clariti
consolid pro-forma balanc sheet cash ow statement use
ling avail date taken preliminari stab pro-forma cash ow
balanc sheet model avail upon request
compani august second quarter confer call provid new
disclosur retain portion rebat within pbm busi data
suggest caremark keep rebat consolid
earn lower gure mani investor suspect push share
esrx higher although addit disclosur well receiv
market prolong lack commun follow administr
blueprint lower drug cost caus continu uncertainti
regulatori landscap prescript drug price continu watch
updat administr believ rel limit
rebat exposur provid investor comfort
pdp overlap suggest roughli pf market share divestitur may
accord latest medicar pdp data cm gov roughli
patient medicar part plan august live
aetna rst fth largest plan sponsor respect
repres roughli total live suggest wall st
journal recent last week like divest portion
medicar pdp busi order satisfi doj anticompetit concern base
cm gov data revenu prot estim deriv use disclosur
provid public player space believ pro-forma
pdp revenu pre-divestitur could annual revenu
annual oper prot roughli adj ep
believ divestitur asset could repres annual
oper prot per share
updat ep estim reect pro-forma model
expect adj ep respect
share current trade roughli new
pro-forma adj ep estim ev/ebitda basi share
look somewhat expens given substanti debt load incur
nanc aetna transact multipl compar averag manag
care multipl ci ev/ebitda averag
pharmaceut suppli chain multipl dplo
price-to-earnings basi also screen cheaper among
group mention also note cheapest compani
health care xlv index maintain price target
assum share eventu trade roughli adj ep
medicar pdp busi greatest area overlap
august medicar pdp enrol stood approxim live
accord see figur live top player account
approxim health largest provid live
follow express script
aetna combin current market share health aetna
result pro-forma market share approxim live
suspect order satisfi potenti doj anti-trust concern
may look divest certain pdp live region overlap two
busi result concern market concentr
figur medicar pdp market share organ
deutsch bank center medicar medicaid servic
figur histor pdp enrol organ
deutsch bank center medicar medicaid servic
pro-forma contribut medicar pdp
estim nancial contribut medicar pdp pro-forma
cvs/aet account asset divestitur seem like
analysi built use pmpm estim medicar pdp premium
deriv wellcar health premium disclosur
oper prot basi assum margin low singl digit rang
consist commentari wellcar sensit
revenu oper prot across assumpt gure
estim medicar pdp busi repres
annual revenu oper prot
estim
prot estim
among cheapest stock xlv
remain among cheapest stock xlv healthcar index
gure indic stock current compris xlv rank
ascend order forward price-to-earnings gure suggest
ep dbe cheapest stock index
parent health express script hold aetna wellcar health plan year live full year revenu oper profit margin estim septemb
price current end previou trade session unless otherwis indic sourc local exchang via reuter bloomberg vendor
inform sourc deutsch bank subject compani sourc disclosur pertain recommend estim made secur
primari subject research pleas see recent publish compani report visit global disclosur look-up page websit http //research db com/
research/disclosures/companysearch asid within report import risk conict disclosur also found http //research db com/research/topics/equ
investor strongli encourag review inform invest
view express report accur reect person view undersign lead analyst
subject issuer secur issuer addit undersign lead analyst receiv
compens provid specic recommend view report glen santangelo
histor recommend target price health corp
recommendationsbuyholdsellnot ratedsuspend rate analyst longer atdeutsch bankdatesecur target price chang usd georg target price chang usd georg target price chang usd georg target price chang usd georg target price chang usd georg target price chang usd georg target price chang usd georg buy target price chang usd target price chang usd georg hill septemb
equiti rate dispers bank relationship
buy base current month view total share-hold
return tsr percentag chang share price current
price project target price plu pro-ject dividend yield
recommend investor buy stock
sell base current view total share-hold
return recommend investor sell stock
hold take neutral view stock
base time horizon recommend either buy
sell
newli issu research recommend target price
inform opinion report prepar deutsch bank ag one aliat collect
deutsch bank though inform herein believ reliabl obtain public sourc
believ reliabl deutsch bank make represent accuraci complet hyperlink third-
parti websit report provid reader conveni deutsch bank neither endors content
respons accuraci secur control websit
use servic deutsch bank connect purchas sale secur discuss report
includ discuss anoth commun oral written deutsch bank analyst deutsch bank may
act princip account agent anoth person
deutsch bank may consid report decid trade princip may also engag transact
account custom manner inconsist view taken research report other within
deutsch bank includ strategist sale sta analyst may take view inconsist taken
research report deutsch bank issu varieti research product includ fundament analysi equity-link
analysi quantit analysi trade idea recommend contain one type commun may dier
recommend contain other whether result dier time horizon methodolog perspect
otherwis deutsch bank and/or aliat may also hold debt equiti secur issuer write
analyst paid part base protabl deutsch bank ag aliat includ invest
bank trade princip trade revenu
opinion estim project constitut current judgment author date report
necessarili reect opinion deutsch bank subject chang without notic deutsch bank provid
liquid buyer seller secur issu compani cover deutsch bank research analyst sometim
shorter-term trade idea may inconsist deutsch bank exist long-term rate trade
idea equiti list catalyst call research websit http //research db com/research/
found gener coverag list also cover compani page catalyst call repres high-convict
belief analyst stock outperform under-perform market and/or speci sector time frame
less two week three month addit catalyst call analyst may occasion discuss
client deutsch bank salesperson trader trade strategi idea refer catalyst
event may near-term medium-term impact market price secur discuss report
impact may direct counter analyst current view total return invest return
describ herein deutsch bank oblig updat modifi amend report otherwis notifi recipi
thereof opinion forecast estim chang becom inaccur coverag frequenc chang
market condit gener company-spec econom prospect make dicult updat research
dene interv updat sole discret coverag analyst research depart manag
major report publish irregular interv report provid inform purpos
take account particular invest object nancial situat need individu client
oer solicit oer buy sell nancial instrument particip particular trade strategi
price inher imprecis product analyst judgment nancial instrument discuss
report may suitabl investor investor must make inform invest decis
price avail nancial instrument subject chang without notic invest transact lead
loss result price uctuat factor nancial instrument denomin currenc
investor currenc chang exchang rate may advers aect invest past perform
necessarili indic futur result perform calcul exclud transact cost unless otherwis indic
unless otherwis indic price current end previou trade session sourc local
exchang via reuter bloomberg vendor data also sourc deutsch bank subject compani
parti
deutsch research depart independ busi divis detail regard
organiz arrang inform barrier prevent avoid conict interest respect
research avail websit http //research db com/research/ disclaim
macroeconom uctuat often account risk associ exposur instrument promis
pay xed variabl interest rate investor long xed-rat instrument thu receiv cash
ow increas interest rate natur lift discount factor appli expect cash ow thu
caus loss longer matur certain cash ow higher move discount factor
higher loss upsid surpris inat scal fund need fx depreci rate among
common advers macroeconom shock receiv counterparti exposur issuer creditworthi client
segment regul includ chang asset hold limit dierent type investor chang tax
polici currenc convert may constrain currenc convers repatri prot and/or liquid
posit settlement issu relat local clear hous also import risk factor sensit xed-
incom instrument macroeconom shock may mitig index contract cash ow inat
fx depreci speci interest rate common emerg market index xing may
construct lag mis-measur actual move underli variabl intend track choic
proper xing metric particularli import swap market oat coupon rate coupon index
typic short-dat interest rate refer index exchang xed coupon fund currenc dier
currenc coupon denomin carri fx risk option swap swaption risk typic
option addit risk relat rate movement
deriv transact involv numer risk includ market counterparti default illiquid risk
appropri product use investor depend investor circumst includ
tax posit regulatori environ natur asset liabil investor
take expert legal nancial advic enter transact similar inspir content
public risk loss futur trade option foreign domest substanti result
high degre leverag obtain futur option trade loss may incur greater
amount fund initi deposit theoret unlimit loss trade option involv risk
suitabl investor prior buy sell option investor must review characterist risk
standard option http //www optionsclear com/about/publications/character-risk jsp unabl
access websit pleas contact deutsch bank repres copi import document
particip foreign exchang transact may incur risk aris sever factor includ follow
exchang rate volatil subject larg uctuat ii valu currenc may aect numer
market factor includ world nation econom polit regulatori event event equiti debt market
chang interest rate iii currenc may subject devalu government-impos exchang control
could aect valu currenc investor secur adr whose valu aect
currenc underli secur eectiv assum currenc risk
unless govern law provid otherwis transact execut deutsch bank entiti
investor home jurisdict asid within report import conict disclosur also found
